Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

1.

Translational potential of olfactory mucosa for the study of neuropsychiatric illness.

Borgmann-Winter K, Willard SL, Sinclair D, Mirza N, Turetsky B, Berretta S, Hahn CG.

Transl Psychiatry. 2015 Mar 17;5:e527. doi: 10.1038/tp.2014.141. Review.

2.

Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder.

Foa EB, Simpson HB, Rosenfield D, Liebowitz MR, Cahill SP, Huppert JD, Bender J Jr, McLean CP, Maher MJ, Campeas R, Hahn CG, Imms P, Pinto A, Powers MB, Rodriguez CI, Van Meter PE, Vermes D, Williams MT.

J Clin Psychiatry. 2014 Oct 14. [Epub ahead of print]

PMID:
25375780
3.

Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia.

Banerjee A, Wang HY, Borgmann-Winter KE, MacDonald ML, Kaprielian H, Stucky A, Kvasic J, Egbujo C, Ray R, Talbot K, Hemby SE, Siegel SJ, Arnold SE, Sleiman P, Chang X, Hakonarson H, Gur RE, Hahn CG.

Mol Psychiatry. 2014 Oct 21. doi: 10.1038/mp.2014.115. [Epub ahead of print]

PMID:
25330739
4.

Norovirus outbreak at a wildland fire base camp ignites investigation of restaurant inspection policies.

Britton CL, Guzzle PL, Hahn CG, Carter KK.

J Environ Health. 2014 Jul-Aug;77(1):8-14; quiz 44.

PMID:
25185322
5.

Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.

Tatard-Leitman VM, Jutzeler CR, Suh J, Saunders JA, Billingslea EN, Morita S, White R, Featherstone RE, Ray R, Ortinski PI, Banerjee A, Gandal MJ, Lin R, Alexandrescu A, Liang Y, Gur RE, Borgmann-Winter KE, Carlson GC, Hahn CG, Siegel SJ.

Biol Psychiatry. 2015 Mar 15;77(6):556-68. doi: 10.1016/j.biopsych.2014.06.026. Epub 2014 Jul 18.

PMID:
25156700
6.

Parvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits.

Billingslea EN, Tatard-Leitman VM, Anguiano J, Jutzeler CR, Suh J, Saunders JA, Morita S, Featherstone RE, Ortinski PI, Gandal MJ, Lin R, Liang Y, Gur RE, Carlson GC, Hahn CG, Siegel SJ.

Neuropsychopharmacology. 2014 Jun;39(7):1603-13. doi: 10.1038/npp.2014.7. Epub 2014 Feb 14.

PMID:
24525709
7.

Increased Stability of Microtubules in Cultured Olfactory Neuroepithelial Cells from Individuals with Schizophrenia.

Brown AS, Borgmann-Winter K, Hahn CG, Role L, Talmage D, Gur R, Chow J, Prado P, McCloskey T, Bao Y, Bulinski JC, Dwork AJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 24. pii: S0278-5846(13)00236-4. doi: 10.1016/j.pnpbp.2013.10.015. [Epub ahead of print]

8.

Juvenile exposure to ketamine causes delayed emergence of EEG abnormalities during adulthood in mice.

Featherstone RE, Nagy LR, Hahn CG, Siegel SJ.

Drug Alcohol Depend. 2014 Jan 1;134:123-7. doi: 10.1016/j.drugalcdep.2013.09.017. Epub 2013 Sep 27.

9.

Proteoglycan abnormalities in olfactory epithelium tissue from subjects diagnosed with schizophrenia.

Pantazopoulos H, Boyer-Boiteau A, Holbrook EH, Jang W, Hahn CG, Arnold SE, Berretta S.

Schizophr Res. 2013 Nov;150(2-3):366-72. doi: 10.1016/j.schres.2013.08.013. Epub 2013 Sep 10.

10.

Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.

Simpson HB, Foa EB, Liebowitz MR, Huppert JD, Cahill S, Maher MJ, McLean CP, Bender J Jr, Marcus SM, Williams MT, Weaver J, Vermes D, Van Meter PE, Rodriguez CI, Powers M, Pinto A, Imms P, Hahn CG, Campeas R.

JAMA Psychiatry. 2013 Nov;70(11):1190-9. doi: 10.1001/jamapsychiatry.2013.1932.

11.

Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder.

Foa EB, Simpson HB, Liebowitz MR, Powers MB, Rosenfield D, Cahill SP, Campeas R, Franklin M, Hahn CG, Hembree EA, Huppert JD, Schmidt AB, Vermes D, Williams MT.

J Clin Psychiatry. 2013 May;74(5):464-9. doi: 10.4088/JCP.12m08017.

12.

Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis.

Moberg PJ, Kamath V, Marchetto DM, Calkins ME, Doty RL, Hahn CG, Borgmann-Winter KE, Kohler CG, Gur RE, Turetsky BI.

Schizophr Bull. 2014 Jan;40(1):50-9. doi: 10.1093/schbul/sbt049. Epub 2013 May 2.

13.

Are we getting closer to valid translational models for major depression?

Berton O, Hahn CG, Thase ME.

Science. 2012 Oct 5;338(6103):75-9. doi: 10.1126/science.1222940. Review.

PMID:
23042886
14.

Biochemical fractionation and stable isotope dilution liquid chromatography-mass spectrometry for targeted and microdomain-specific protein quantification in human postmortem brain tissue.

MacDonald ML, Ciccimaro E, Prakash A, Banerjee A, Seeholzer SH, Blair IA, Hahn CG.

Mol Cell Proteomics. 2012 Dec;11(12):1670-81. doi: 10.1074/mcp.M112.021766. Epub 2012 Aug 31.

15.

HDAC6 regulates glucocorticoid receptor signaling in serotonin pathways with critical impact on stress resilience.

Espallergues J, Teegarden SL, Veerakumar A, Boulden J, Challis C, Jochems J, Chan M, Petersen T, Deneris E, Matthias P, Hahn CG, Lucki I, Beck SG, Berton O.

J Neurosci. 2012 Mar 28;32(13):4400-16. doi: 10.1523/JNEUROSCI.5634-11.2012.

16.

Variability in cancer death certificate accuracy by characteristics of death certifiers.

Johnson CJ, Hahn CG, Fink AK, German RR.

Am J Forensic Med Pathol. 2012 Jun;33(2):137-42. doi: 10.1097/PAF.0b013e318219877e.

PMID:
21490500
17.

A Src link in schizophrenia.

Hahn CG.

Nat Med. 2011 Apr;17(4):425-7. doi: 10.1038/nm0411-425. No abstract available.

PMID:
21475235
18.

Two clusters of HIV-1 infection, rural Idaho, USA, 2008.

Nett RJ, Bartschi JL, Ellis GM, Hachey DM, Frenkel LM, Roscoe JC, Carter KK, Hahn CG.

Emerg Infect Dis. 2010 Nov;16(11):1807-9. doi: 10.3201/eid1611.100857. No abstract available.

19.

A road less travelled: unpacking the complex traits of schizophrenia.

Hahn CG.

Brain Res Bull. 2010 Sep 30;83(3-4):85. doi: 10.1016/j.brainresbull.2010.05.007. Epub 2010 May 28. No abstract available.

PMID:
20546839
20.

Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.

Banerjee A, Macdonald ML, Borgmann-Winter KE, Hahn CG.

Brain Res Bull. 2010 Sep 30;83(3-4):132-9. doi: 10.1016/j.brainresbull.2010.04.011. Epub 2010 Apr 28. Review.

PMID:
20433909
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk